Clinical Evaluation of Therapeutic Meibomian Gland Expression
NCT04997135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2021-12-01
Summary
This will be a single centre pilot study to evaluate appearance of the Meibomian glands.
Conditions
- Visual Acuity
- Meibomian Gland
Sponsors & Collaborators
-
Johnson & Johnson Vision Care, Inc.
lead INDUSTRY
Principal Investigators
-
Johnson & Johnson Vision Care, Inc. Clinical Trial · Johnson & Johnson Vision Care, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-15
- Primary Completion
- 2021-11-11
- Completion
- 2021-11-11
Countries
- United Kingdom
Study Locations
More Related Trials
-
Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction
NCT04120584 ·Status: COMPLETED ·Phase: NA
-
Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
NCT05145959 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
NCT00832130 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of the Clinical Utility and Safety of the Visant Medical Canalicular Plug
NCT04817085 ·Status: COMPLETED ·Phase: NA
-
Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction
NCT01979887 ·Status: COMPLETED
-
Meibomian Gland Dysfunction Treatment
NCT04229888 ·Status: COMPLETED ·Phase: NA
-
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
NCT02102464 ·Status: COMPLETED ·Phase: NA
-
Clinical Effect of MiboFlo in Dry Eye Patients
NCT04310969 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction
NCT04889950 ·Status: COMPLETED ·Phase: NA
-
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01091311 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Meibomian Gland Dysfunction in Chinese Old Patients
NCT02481167 ·Status: UNKNOWN
-
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
NCT04280653 ·Status: COMPLETED ·Phase: NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
NCT03658811 ·Status: COMPLETED ·Phase: NA
-
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT05162261 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effect of At Home Thermal Therapy on Dry Eye Patients With Meibomian Gland Dysfunction
NCT03291704 ·Status: UNKNOWN ·Phase: NA
-
Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis
NCT04085016 ·Status: COMPLETED
-
Treatment Regimens in Meibomian Gland Dysfunction
NCT05594745 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Eye Make up on Ocular Surface
NCT04478955 ·Status: UNKNOWN
-
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
NCT07039461 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)
NCT05683496 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease
NCT05857748 ·Status: WITHDRAWN
-
Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction
NCT02618304 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FID 114657 in Dry Eye Subjects
NCT01079858 ·Status: COMPLETED ·Phase: NA